2026-10-22 13:42:00 UTC#500435newconfirmednews
ETRA stock news
ETRA stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire17 wire items
2026-10-13 20:11:00 UTC#454758newconfirmednews
Jefferies initiates coverage of Electra Therapeutics at Buy
dow_jonesimportance 0.30trust 0.70Electra Therapeutics, Inc. +0.40Jefferies Financial Group Inc. +0.40
2026-10-13 17:55:00 UTC#454174newconfirmednews
Evercore ISI Group initiates coverage of Electra Therapeutics at Outperform
2026-09-25 21:36:00 UTC#371215newconfirmednews
OrbiMed Advisors discloses 11.0% stake in Electra Therapeutics following IPO
2026-09-18 09:47:00 UTC#332430duplicateconfirmednews
Electra Therapeutics Prices Upsized $350 Million IPO at $15 Per Share
2026-09-18 00:37:00 UTC#330628duplicateconfirmednews
Electra Therapeutics (ETRA) prices 23.3 million IPO shares at $15 each
2026-09-18 00:37:00 UTC#330627updateconfirmedpress release
Electra Therapeutics (ETRA) grants underwriters 30-day option for 3.5M additional shares in IPO
2026-09-18 00:37:00 UTC#330625duplicateconfirmednews
Electra Therapeutics (ETRA) shares begin trading on Nasdaq Global Select Market
2026-09-18 00:37:00 UTC#330624updateconfirmednews
Electra Therapeutics (ETRA) expects $350 million IPO to close September 21
2026-09-18 00:37:00 UTC#330623duplicateconfirmednews
Electra Therapeutics (ETRA) confirms $350 million gross proceeds from IPO
2026-09-18 00:30:53 UTC#330608newconfirmedpress release
Electra Therapeutics Prices Upsized $350 Million IPO at $15 Per Share
2026-09-18 00:30:00 UTC#330616duplicateconfirmednews
Electra Therapeutics Prices Upsized $350M IPO at $15/Share, Trading Begins Sept 18 on Nasdaq
2026-09-18 00:30:00 UTC#330613duplicateconfirmedpress release
Electra Therapeutics prices upsized $350 million IPO at $15 per share
2026-09-14 13:25:08 UTC#307608duplicateconfirmednews
Electra Therapeutics confirms IPO pricing of 21.67 million shares at $14-$16 range
2026-09-14 10:57:10 UTC#306576updateconfirmednews
Electra Therapeutics targets $977.6 million valuation in US IPO, raising up to $346.7 million
reutersimportance 0.40trust 0.90Electra Therapeutics, Inc. +0.30ipsoprubart +0.20South San Francisco 0+2 entities
2026-09-14 10:20:00 UTC#306400updateconfirmednews
Electra Therapeutics sets IPO for 21.7 million shares at $14-$16 range, targeting $905 million valuation
2026-08-28 20:17:00 UTC#237153newconfirmednews
Electra Therapeutics files for IPO on Nasdaq under ticker ETRA to fund clinical development of ipsoprubart
dow_jonesimportance 0.50trust 0.90Electra Therapeutics, Inc. +0.20Securities and Exchange Commission 0ipsoprubart +0.20+1 entities